Cyclana Bio Ltd develops tissue‑level drug discovery platforms to create new therapeutics for women’ Sign up to read more
| Allotment | Filed | Share Class | Round Size | Round Type |
|---|---|---|---|---|
2025-10-28 | £4.9M |
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| LEA MARION DENISE WENGER | ORDINARY | 100,000 | 31.0% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
Companies with the most similar business descriptions.
Capital raised per employee divides the equity CYCLANA BIO LTD raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
A share class is a category of shares carrying its own rights over voting, dividends and what happens to the money if the company is sold or wound up. UK companies typically issue Ordinary shares to founders and employees, then create a new Preferred class at each funding round, giving investors priority on proceeds ahead of the Ordinary holders. CYCLANA BIO LTD has 2 distinct classes on file at Companies House; the rights attached to each are reproduced below as filed.
EACH ORDINARY SHARE CARRIES ONE VOTE, RANKS EQUALLY WITH THE PRE-SEED SHARES IN ALL RESPECTS, INCLUDING AS TO PARTICIPATION IN ANY DISTRIBUTION AND AS RESPECTS DIVIDENDS, SAVE FOR ON A DISTRIBUTION OF ASSETS ON A LIQUIDATION, RETURN OF CAPITAL OR SALE WHERE ANY SURPLUS ASSETS OR PROCEEDS OF SALE SHALL BE REPAID (I) IN PAYING THE HOLDERS OF DEFERRED SHARES (IF ANY) £0.01 IN AGGREGATE; (II) THEN TO THE HOLDERS OF PRE-SEED SHARES THE GREATER OF £35.6101 PLUS ARREARS OF UNPAID DIVIDENDS PER PRE-SEED SHARE AND THE AMOUNT THAT WOULD BE DISTRIBUTED IF SUCH PRE-SEED SHARES WERE CONVERTED INTO ORDINARY SHARES IMMEDIATELY BEFORE DISTRIBUTION; AND (III) THEN TO THE REMAINING HOLDERS OF ORDINARY SHARES PRO RATA TO THE NUMBER OF SHARES HELD BY THEM. THE ORDINARY SHARES ARE NOT REDEEMABLE.
EACH PRE-SEED SHARE CARRIES ONE VOTE, RANKS EQUALLY WITH THE ORDINARY SHARES IN ALL RESPECTS, INCLUDING AS TO PARTICIPATION IN ANY DISTRIBUTION AND AS RESPECTS DIVIDENDS, SAVE FOR ON A DISTRIBUTION OF ASSETS ON A LIQUIDATION, RETURN OF CAPITAL OR SALE WHERE ANY SURPLUS ASSETS OR PROCEEDS OF SALE SHALL BE REPAID (I) IN PAYING THE HOLDERS OF DEFERRED SHARES (IF ANY) £0.01 IN AGGREGATE; (II) THEN TO THE HOLDERS OF PRE-SEED SHARES THE GREATER OF £35.6101 PLUS ARREARS OF UNPAID DIVIDENDS PER PRE-SEED SHARE AND THE AMOUNT THAT WOULD BE DISTRIBUTED IF SUCH PRE-SEED SHARES WERE CONVERTED INTO ORDINARY SHARES IMMEDIATELY BEFORE DISTRIBUTION; AND (III) THEN TO THE REMAINING HOLDERS OF ORDINARY SHARES PRO RATA TO THE NUMBER OF SHARES HELD BY THEM.THE PRE-SEED SHARES ARE NOT REDEEMABLE.
These are the directors and secretaries who have left CYCLANA BIO LTD. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.
| 88888888 |
| 888888 |
| 8888 |
12 more shareholders on file , sign up free to see.